News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
557,520 Results
Type
Article (45091)
Company Profile (135)
Press Release (512294)
Section
Business (155148)
Career Advice (2399)
Deals (28998)
Drug Delivery (113)
Drug Development (71106)
Employer Resources (148)
FDA (15757)
Job Trends (12436)
News (278383)
Policy (30451)
Tag
Academia (2348)
Alliances (36859)
Alzheimer's disease (1356)
Antibody-drug conjugate (ADC) (105)
Approvals (15686)
Artificial intelligence (152)
Bankruptcy (309)
Best Places to Work (9635)
Breast cancer (197)
Cancer (1477)
Cardiovascular disease (129)
Career advice (2000)
CAR-T (106)
Cell therapy (309)
Clinical research (56938)
Collaboration (495)
Compensation (307)
COVID-19 (2605)
C-suite (125)
Data (1391)
Diabetes (190)
Diagnostics (5357)
Drug pricing (109)
Earnings (64822)
Employer resources (136)
Events (89822)
Executive appointments (440)
FDA (16524)
Funding (447)
Gene therapy (226)
GLP-1 (701)
Government (4052)
Healthcare (15538)
Infectious disease (2704)
Inflammatory bowel disease (110)
Interviews (446)
IPO (14451)
Job creations (3195)
Job search strategy (1667)
Layoffs (463)
Legal (7137)
Lung cancer (221)
Manufacturing (208)
Medical device (11475)
Medtech (11478)
Mergers & acquisitions (14789)
Metabolic disorders (540)
Neuroscience (1725)
NextGen: Class of 2025 (5196)
Non-profit (3369)
Northern California (1754)
Obesity (317)
Opinion (202)
Patents (132)
People (43635)
Phase I (16873)
Phase II (24753)
Phase III (20161)
Pipeline (618)
Postmarket research (2375)
Preclinical (6958)
Radiopharmaceuticals (215)
Rare diseases (295)
Real estate (4396)
Regulatory (20903)
Research institute (2094)
Resumes & cover letters (402)
Southern California (1491)
Startups (2814)
United States (15086)
Vaccines (650)
Weight loss (248)
Date
Today (129)
Last 7 days (370)
Last 30 days (1874)
Last 365 days (32053)
2025 (1673)
2024 (32384)
2023 (36362)
2022 (46517)
2021 (50204)
2020 (47192)
2019 (38128)
2018 (28869)
2017 (28820)
2016 (27344)
2015 (30615)
2014 (24114)
2013 (19572)
2012 (21041)
2011 (21512)
2010 (19458)
Location
Africa (678)
Arizona (156)
Asia (32021)
Australia (5587)
California (3904)
Canada (1241)
China (299)
Colorado (173)
Connecticut (202)
Europe (77426)
Florida (561)
Georgia (132)
Illinois (347)
Indiana (203)
Maryland (648)
Massachusetts (3031)
Michigan (152)
Minnesota (276)
New Jersey (1101)
New York (1087)
North Carolina (743)
Northern California (1754)
Ohio (126)
Pennsylvania (894)
South America (1045)
Southern California (1491)
Texas (546)
Washington State (394)
557,520 Results for "recordati s p a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Recordati Announces Agreement to Acquire the Global Rights to Enjaymo®, Strengthening Its Rare Diseases Franchise
October 4, 2024
·
5 min read
Rare diseases
Sanofi Offloads Rare Autoimmune Drug to Recordati in Potential $1B Deal
Under the deal announced Friday, the Italian pharma will make an upfront payment of $825 million to Sanofi for global rights to a biologic for the treatment of cold agglutinin disease, with milestone payments of up to $250 million.
October 4, 2024
·
2 min read
·
Tristan Manalac
Press Releases
RECORDATI: CONTINUED DOUBLE-DIGIT GROWTH IN THE FIRST NINE MONTHS OF 2024 - REVENUE +12.0%, EBITDA(1) +11.8%, ADJUSTED NET INCOME(2) +9.5%
November 11, 2024
·
21 min read
Press Releases
David P. King Joins Truvian’s Advisory Board
January 13, 2025
·
2 min read
Press Releases
Acadia Pharmaceuticals Set to Join S&P SmallCap 600
December 31, 2024
·
1 min read
Press Releases
Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A
January 14, 2025
·
4 min read
Press Releases
Azafaros to Present at J.P. Morgan’s 43rd Annual Healthcare Conference
January 9, 2025
·
3 min read
Press Releases
Axxam S.p.A. accelerates global expansion incorporating Axxam Inc.
December 13, 2024
·
2 min read
Press Releases
Bristol Myers Squibb to Present at J.P. Morgan’s 43rd Annual Healthcare Conference
January 3, 2025
·
1 min read
Press Releases
Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A
December 3, 2024
·
5 min read
1 of 55,752
Next
